Study Title: An Open Label Randomized Phase I/II Trial of MLN0128 Compared to Sorafenib in Patients With Advanced or Metastatic Hepatocellular Carcinoma: Big Ten Cancer Research Consortium BTCRC-GI13-002
 

• Status: Terminated

• Participating Sites:
  • University of Illinois Cancer Center
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
  • University of Michigan Rogel Cancer Center
  • Fred & Pamela Buffett Cancer Center (University of Nebraska)
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Penn State Cancer Institute
  • University of Wisconsin Carbone Cancer Center
  • UNC Lineberger Comprehensive Cancer Center
• Learn more:
  • clinicaltrials.gov: NCT02575339